ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The Dan Lewis Foundation for Brain Regeneration Research Announces First Annual DLF Prize to Be Awarded Spring 2023

The Dan Lewis Foundation for Brain Regeneration Research (the DLF) announces the 2023 DLF Prize.

The Dan Lewis Foundation for Brain Regeneration Research (the DLF) happily announces the 2023 DLF Prize. This $15,000 prize will be awarded to an early career scientist in neuroscience, pharmacology, or biotechnology whose research record and future research plans align with one or more of the DLF's current research priorities. These research priorities are:

  1. Research into pharmacological methods of reactivating or augmenting synaptogenesis
  2. Research into trials of repleting damaged cortex using derived cortical neurons
  3. Research into transcriptomic profiles of cortical neurons during the recovery phase post-brain injury
  4. Research furthering effective design of anti-sense oligonucleotides and/or other small molecule medicines to down-regulate inhibitors of regeneration in the cortex and spinal cord

The DLF Prize application portal is now open and can be accessed at the foundation's website: DanLewisFoundation.org

Submissions of applications are due by March 31, 2023. The DLF Prize will be awarded by May 31, 2023.

Contact Information:
Hal Lewis
hal@danlewisfoundation.org


Original Source: The Dan Lewis Foundation for Brain Regeneration Research Announces First Annual DLF Prize to Be Awarded Spring 2023
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.